Absorption of epirubicin instilled intravesically immediately after transurethral resection of superficial bladder cancer

Urologia Internationalis

Volumn 60, Issue 3, 1998, Pages 161-164

  Tsushima, Tomoyasu ^a,b   Miyaji, Yoshiyuki ^a   Noda, Masatoshi ^a   Nasu, Yasutomo ^a   Kumon, Hiromi ^a   Ohmori, Hiroyuki ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NONE   (Japan)

Author keywords

Absorption; Epirubicin; Intravesical instillation; Superficial bladder cancer; Transurethral resection

Indexed keywords

EPIRUBICIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER MUCOSA; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG PENETRATION; FEMALE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SIDE EFFECT; TRANSURETHRAL RESECTION;

ABSORPTION; ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, TRANSITIONAL CELL; CHEMOTHERAPY, ADJUVANT; EPIRUBICIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 0031819502     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030242     Document Type: Article

References (9)

1. Matsumura Y, Tsushima T, Ozaki Y, Yoshimoto J, Akagi T, Obama T, Nasu Y, Ohmori H: Intravesical chemotherapy with 4′-epi-adriamycin in patients with superficial bladder tumors. Cancer Chemother Pharmacol 1986;16: 176-177.
2. Soloway MS, Masters S: Urothelial susceptibility to tumor cell implantation. Influence of cauterization. Cancer 1980;46:1158-1163.
3. Tsushima T: Fundamental studies on intravesical instillation of 4′-epi-adriamycin for treatment of bladder cancer. Act Urol Jpn 1985;31: 1945-1956.
4. Mross K, Maessen P, van der Vijgh WJF, Bogdanowicz JF, Kurth KH, Pinedo HM: Absorption of epi-doxorubicin after intravesical administration in patients with in situ transitional cell carcinoma of the bladder. Eur J Cancer Clin Oncol 1987;23:505-508.
5. Wajsman Z, Dhafir RA, Pfeffer M, MacDonald S, Block A, Dragone N, Pontes E: Studies of mitomycin C absorption after intravesical treatment of superficial bladder tumors. J Urol 1984;132:30-33.
6. Camaggi CM, Strocchi E, Comparsi R, Testoni F, Amgelelli B, Pannuti F: Biliary excretion and pharmacokinetics of 4′-epidoxorubicin (epirubicin) in advanced cancer patients. Cancer Chemother Pharmacol 1986;18:125-128.
7. Noda M, Tsushima T, Takamatsu M, Kaku S, Saika T, Akebi N, Nasu Y, Ohmori H, Tanahashi T, Namba K, Matsumura Y: Postoperative adjuvant chemotherapy by early intravesical instillation of epirubicin for the treatment of superficial bladder cancer. Jpn J Urol 1993;55: 43-45.
8. Oosterlinck W, Kurth KH, Schröder F, Bultinck J, Hammond B, Sylvester R, Members of the European Organization for Research and Treatment of Cancer Genitourinary Group: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol 1993;149:749-752.
9. Tsushima T, Matsumura Y, Ozaki Y, Yoshimoto J, Ohmori H, Okayama Urological Cancer Collaborating Group (OUCCG): Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer. Cancer Chemother Pharmacol 1987;20(suppl):72-76.